RA Taha, TC Kotsimbos, YL Song, D Menzies and Q Hamid
Meakins Christie Laboratories, Montreal Chest Institute Research Centre, McGill University, Montreal, Quebec, Canada.

Cytokine-mediated immune responses to Mycobacterium tuberculosis infection are important determinants of M. tuberculosis disease development and pathology. However, the distinction between changes in cytokine profile attributable to M. tuberculosis infection and those associated with active pulmonary tuberculosis is unclear. We have compared T cells and their subsets, macrophages, and cytokine messenger RNA (mRNA) profile in the bronchoalveolar lavage (BAL) of patients with active pulmonary tuberculosis with inactive tuberculosis subjects. Ten patients with microbiologically confirmed active pulmonary tuberculosis and 25 subjects with inactive tuberculosis were recruited. Bronchoscopy with BAL was undertaken in all cases and BAL cytospins were examined using the techniques of immunocytochemistry and in situ hybridization. There was a significant increase in the percentage of BAL cells that were CD8+ T cells in active tuberculosis compared with inactive tuberculosis (mean +/- SEM: 7.2 +/- 0.9 versus 2.1 +/- 0.4, p < 0.001), but not CD3+ or CD4+ T cells nor macrophages. There were significant increases in the percentage of BAL cells expressing mRNA for interferon- gamma (IFN-gamma) and interleukin-12 (IL-12) in active versus inactive pulmonary tuberculosis subjects (8.0 +/- 0.6 versus 3.7 +/- 0.4 and 28.4 +/- 2.3 versus 10.2 +/- 1.0, p < 0.001, respectively). There were no significant differences between the active and inactive groups in the number of cells expressing mRNA for IL-2, tumor necrosis factor- alpha (TNF-alpha), IL-4, and IL-5. In conclusion, active pulmonary tuberculosis is associated with increased numbers of CD8+ cells and marked increases in the expression of IL-12 and IFN-gamma mRNA in the BAL, both of which may be useful markers of disease activity.

This article has been cited by other articles:

				N. W. Schluger Assessing tuberculosis transmission and virulence: the vanishing tuberculin skin test. Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 942 - 943. [Full Text] [PDF]

				S. Marino, S. Pawar, C. L. Fuller, T. A. Reinhart, J. L. Flynn, and D. E. Kirschner Dendritic Cell Trafficking and Antigen Presentation in the Human Immune Response to Mycobacterium tuberculosis J. Immunol., July 1, 2004; 173(1): 494 - 506. [Abstract] [Full Text] [PDF]

				M. G. Bonecini-Almeida, J. L. Ho, N. Boechat, R. C. Huard, S. Chitale, H. Doo, J. Geng, L. Rego, L. C. O. Lazzarini, A. L. Kritski, et al. Down-Modulation of Lung Immune Responses by Interleukin-10 and Transforming Growth Factor {beta} (TGF-{beta}) and Analysis of TGF-{beta} Receptors I and II in Active Tuberculosis Infect. Immun., May 1, 2004; 72(5): 2628 - 2634. [Abstract] [Full Text] [PDF]

				C. L. Fuller, J. L. Flynn, and T. A. Reinhart In Situ Study of Abundant Expression of Proinflammatory Chemokines and Cytokines in Pulmonary Granulomas That Develop in Cynomolgus Macaques Experimentally Infected with Mycobacterium tuberculosis Infect. Immun., December 1, 2003; 71(12): 7023 - 7034. [Abstract] [Full Text] [PDF]

				Y. Koguchi, K. Kawakami, K. Uezu, K. Fukushima, S. Kon, M. Maeda, A. Nakamoto, I. Owan, M. Kuba, N. Kudeken, et al. High Plasma Osteopontin Level and Its Relationship with Interleukin-12-mediated Type 1 T Helper Cell Response in Tuberculosis Am. J. Respir. Crit. Care Med., May 15, 2003; 167(10): 1355 - 1359. [Abstract] [Full Text] [PDF]

				Y.-J. Jung, R. LaCourse, L. Ryan, and R. J. North Evidence Inconsistent with a Negative Influence of T Helper 2 Cells on Protection Afforded by a Dominant T Helper 1 Response against Mycobacterium tuberculosis Lung Infection in Mice Infect. Immun., November 1, 2002; 70(11): 6436 - 6443. [Abstract] [Full Text] [PDF]

				T. C. Y. Tsao, C.-H. Chen, J.-h. Hong, M.-J. Hsieh, K.-C. Tsao, and C.-H. Lee Shifts of T4/T8 T Lymphocytes From BAL Fluid and Peripheral Blood by Clinical Grade in Patients With Pulmonary Tuberculosis Chest, October 1, 2002; 122(4): 1285 - 1291. [Abstract] [Full Text] [PDF]

				H. M. Vordermeier, M. A. Chambers, P. J. Cockle, A. O. Whelan, J. Simmons, and R. G. Hewinson Correlation of ESAT-6-Specific Gamma Interferon Production with Pathology in Cattle following Mycobacterium bovis BCG Vaccination against Experimental Bovine Tuberculosis Infect. Immun., June 1, 2002; 70(6): 3026 - 3032. [Abstract] [Full Text] [PDF]

				R. van Crevel, T. H. M. Ottenhoff, and J. W. M. van der Meer Innate Immunity to Mycobacterium tuberculosis Clin. Microbiol. Rev., April 1, 2002; 15(2): 294 - 309. [Abstract] [Full Text] [PDF]

				V. Dheenadhayalan, S. Shanmugalakshmi, S. Vani, P. Muthuveeralakshmi, G. Arivarignan, A. D. Nageswari, and R M. Pitchappan Association of Interleukin-10 Cytokine Expression Status with HLA Non-DRB1*02 and Mycobacterium bovis BCG Scar-Negative Status in South Indian Pulmonary Tuberculosis Patients Infect. Immun., September 1, 2001; 69(9): 5635 - 5642. [Abstract] [Full Text] [PDF]

				J. E. Wigginton and D. Kirschner A Model to Predict Cell-Mediated Immune Regulatory Mechanisms During Human Infection with Mycobacterium tuberculosis J. Immunol., February 1, 2001; 166(3): 1951 - 1967. [Abstract] [Full Text] [PDF]

				S. G. Rhodes, N. Palmer, S. P. Graham, A. E. Bianco, R. G. Hewinson, and H. M. Vordermeier Distinct Response Kinetics of Gamma Interferon and Interleukin-4 in Bovine Tuberculosis Infect. Immun., September 1, 2000; 68(9): 5393 - 5400. [Abstract] [Full Text] [PDF]

				P. F. Barnes and B. Wizel Type 1 Cytokines and the Pathogenesis of Tuberculosis Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1773 - 1774. [Full Text]

				G. YAMADA, N. SHIJUBO, K. SHIGEHARA, H. OKAMURA, M. KURIMOTO, and S. ABE Increased Levels of Circulating Interleukin-18 in Patients with Advanced Tuberculosis Am. J. Respir. Crit. Care Med., June 1, 2000; 161(6): 1786 - 1789. [Abstract] [Full Text]

				S. Bhattacharyya, R. Singla, A. B. Dey, and H. K. Prasad Dichotomy of Cytokine Profiles in Patients and High-Risk Healthy Subjects Exposed to Tuberculosis Infect. Immun., November 1, 1999; 67(11): 5597 - 5603. [Abstract] [Full Text] [PDF]

				R. A. TAHA, E. M. MINSHALL, R. OLIVENSTEIN, D. IHAKU, B. WALLAERT, A. TSICOPOULOS, A.-B. TONNEL, R. DAMIA, D. MENZIES, and Q. A. HAMID Increased Expression of IL-12 Receptor mRNA in Active Pulmonary Tuberculosis and Sarcoidosis Am. J. Respir. Crit. Care Med., October 1, 1999; 160(4): 1119 - 1123. [Abstract] [Full Text]

				A. Sauty, M. Dziejman, R. A. Taha, A. S. Iarossi, K. Neote, E. A. Garcia-Zepeda, Q. Hamid, and A. D. Luster The T Cell-Specific CXC Chemokines IP-10, Mig, and I-TAC Are Expressed by Activated Human Bronchial Epithelial Cells J. Immunol., March 15, 1999; 162(6): 3549 - 3558. [Abstract] [Full Text] [PDF]

				M. CASARINI, F. AMEGLIO, L. ALEMANNO, P. ZANGRILLI, P. MATTIA, G. PAONE, A. BISETTI, and S. GIOSUÈ Cytokine Levels Correlate with a Radiologic Score in Active Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., January 1, 1999; 159(1): 143 - 148. [Abstract] [Full Text]

				S. GIOSUE, M. CASARINI, L. ALEMANNO, G. GALLUCCIO, P. MATTIA, G. PEDICELLI, L. REBEK, A. BISETTI, and F. AMEGLIO Effects of Aerosolized Interferon-alpha in Patients with Pulmonary Tuberculosis Am. J. Respir. Crit. Care Med., October 1, 1998; 158(4): 1156 - 1162. [Abstract] [Full Text] [PDF]

				N. W. SCHLUGER and W. N. ROM The Host Immune Response to Tuberculosis Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 679 - 691. [Full Text] [PDF]